AllucentBracknell, England, United Kingdom
Disclosure information not submitted.
126 - Modeling Confirms Islatravir 0.25 mg Administered Daily Has No Adverse Effect on Total Lymphocyte or CD4+ T-cell Counts in People Living with HIV
Monday, October 20, 202512:15 PM - 12:20 PM US ET